View More Recent Stories

Nov 10, 2022 07:55AM Senti Bio Reports Third Quarter Financial Results and Pipeline Updates
Nov 10, 2022 07:55AM Senti Bio Reports Third Quarter Financial Results and Pipeline Updates
Nov 3, 2022 09:05AM Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH Annual Meeting
Nov 3, 2022 09:05AM Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH Annual Meeting
Oct 28, 2022 04:05PM Senti Bio Announces New Employment Inducement Grants
Oct 28, 2022 04:05PM Senti Bio Announces New Employment Inducement Grants
Oct 5, 2022 08:01AM Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at SITC Annual Meeting
Oct 5, 2022 08:01AM Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at SITC Annual Meeting
Sep 20, 2022 04:02PM Senti Bio to Participate in Chardan’s 6th Annual Genetic Medicines Conference
Sep 20, 2022 04:02PM Senti Bio to Participate in Chardan’s 6th Annual Genetic Medicines Conference
Sep 6, 2022 04:01PM Senti Bio to Present at Morgan Stanley 20th Annual Global Healthcare Conference
Sep 6, 2022 04:01PM Senti Bio to Present at Morgan Stanley 20th Annual Global Healthcare Conference
Aug 19, 2022 04:05PM Senti Biosciences Announces New Employment Inducement Grants
Aug 19, 2022 04:05PM Senti Biosciences Announces New Employment Inducement Grants
Aug 15, 2022 04:05PM Senti Bio Reports Second Quarter Financial Results and Business Updates
Aug 15, 2022 04:05PM Senti Bio Reports Second Quarter Financial Results and Business Updates
Jun 9, 2022 07:33AM Senti Bio (SNTI) Debuts as Publicly Traded Company
Jun 9, 2022 07:30AM Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits
View More Recent Stories